1. Sakurai A, Nakai A, DeGroot LJ. Expression of three forms of thyroid hormone receptor in human tissues. Mol Endocrinol 1989;3:392-9.
2. Shahrara S, Drvota V, Sylven C. Organ specific expression of thyroid hormone receptor mRNA and protein in different human tissues. Biol Pharm Bull 1999;22:1027-33.
3. Geracioti TD, Jr. How to identify hypothyroidism’s psychiatric presentations. Current Psychiatry 2006;5(11):98-117.
4. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-99.
5. Bianchi GP, Zaccheroni V, Vescini F, et al. Health-related quality of life in patients with thyroid disorders. Qual Life Res 2004;13:45-54.
6. Thomsen AF, Kvist TK, Andersen OK, Kessing LV. Increased risk of affective disorder following hospitalization with hyperthyroidism—a register-based study. Eur J Endocrinol 2005;152:535-43.
7. Grabe HJ, Volzke H, Ludermann J, et al. Mental and physical complaints in thyroid disorders in the general population. Acta Psychiatr Scand 2005;112:286-93.
8. Kathol RG, Delahunt JW. The relationship of anxiety and depression to symptoms of hyperthyroidism using operational criteria. Gen Hosp Psychiatry 1986;8:23-8.
9. Trzepacz PT, McCue M, Klein I, et al. A psychiatric and neuropsychological study of patients with untreated Graves’ disease. Gen Hosp Psychiatry 1988;10:49-55.
10. Bunevicius R, Velickiene D, Prange AJ, Jr. Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves’ disease. Gen Hosp Psychiatry 2005;27:133-9.
11. Larson PR, Davies TF, Hay ID. The thyroid gland. In: Wilson JD, Forster DW, Kronenberg HM, Larsen PR eds. Williams textbook of endocrinology. 9th ed. Philadelphia, PA: WB Saunders;1998:389-515.
12. Matsubayashi S, Tamai H, Matsumoto Y, et al. Graves’ disease after the onset of panic disorder. Psychother Psychosom 1996;65(5):277-80.
13. Lazarus JH. Hyperthyroidism. Lancet 1997;349:339-43.
14. Pearce EN. Diagnosis and management of thyrotoxicosis. BMJ 2006;332:1369-73.
15. Utiger RD. The thyroid: physiology, thyrotoxicosis, hypothyroidism, and the painful thyroid. In: Felig P, Frohman LA, eds. Endocrinology and metabolism, 4th ed. New York, NY: McGraw-Hill; 2001:261-347.
16. Beckers A, Abs R, Mahler C, et al. Thyrotropin-secreting pituitary adenomas: report of seven cases. J Clin Endocrinol Metab 1991;72:477-83.
17. Kinder BK, Burrow GN. The thyroid: nodules and neoplasiaIn: Felig P, Frohman LA eds. Endocrinology and metabolism, 4th ed New York, NY: McGraw-Hill; 2001:349-383.
18. Prange AJ, Jr, Wilson IC, Rabon AM, Lipton MA. Enhancement of imipramine antidepressant activity by thyroid hormone. Am J Psychiatry 1969;126:457-69.
19. Geracioti TD, Jr, Loosen PT, Gold PW, Kling MA. Cortisol, thyroid hormone, and mood in atypical depression: a longitudinal case study. Biol Psychiatry 1992;31:515-9.
20. Geracioti TD, Kling MA, Post R, Gold PW. Antithyroid antibody-linked symptoms in borderline personality disorder. Endocrine 2003;21:153-8.
21. Bocchetta A, Mossa P, Velluzzi F, et al. Ten-year follow-up of thyroid function in lithium patients. J Clin Psychopharmacol 2001;21:594-8.
